RareCyte, Inc.

943 posts

RareCyte, Inc. banner
RareCyte, Inc.

RareCyte, Inc.

@RareCyte

Unmatched Clarity in Spatial Biology & Liquid Biopsy

Seattle, WA Katılım Temmuz 2016
141 Takip Edilen372 Takipçiler
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
Real or cake? 🎂 It's a tough one, we know. It was great getting our team together this week and celebrating the launch of Orion HT! Check out Orion HT on our website to see how close this cake is to the real thing: development.rarecyte.com/orion-ht.html
RareCyte, Inc. tweet media
English
0
0
0
13
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
What is the impact of circulating tumor cell testing in clinical research? Hear from @pashtoonkasi (City of Hope) on the insights that CTCs uniquely give you, and how they complement tissue-based and circulating tumor DNA approaches. #AACR26 #AACR2026 #LiquidBiopsy
English
3
6
4
922
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
📣 RareCyte announces launch of Orion HT and Orion LE systems, extending the Orion platform across the full continuum of translational research, from early assay development and validation through clinical trial execution. ➡️ Read the press release: rarecyte.com/news-2026.04.2…
RareCyte, Inc. tweet media
English
0
0
0
33
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
This study demonstrates the feasibility and robust performance of the CDH17 CTC assay in blood and cerebrospinal fluid of a colorectal cancer patient. ☑️Powered by RareCyte's CyteFinder platform #AACR2026 #AACR26
Pashtoon Kasi MD, MS@pashtoonkasi

#AACR26 See our work that challenges so many dogmas about #LiquidBiopsies for cancer. ⚫️Not just DNA🧬, CTCs👇🏽 ⚫️Not just blood, CSF🧠 ⚫️Not just prognostic, predictive🎯CDH17 ⚫️Kinetics🟰📉response CSF cytology was negative ➖ So many💡 🔗abstractsonline.com/pp8/#!/21436/p… @OncoAlert

English
0
0
0
37
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
17-plex single-round imaging of human gastric adenocarcinoma, acquired on the Orion platform. 📸 This image, courtesy of Shumpei Ishikawa, PhD, from @UTokyo_News is featured in the RareCyte 2026 Calendar. View all images featured this year’s calendar: rarecyte.com/2026calendar/
RareCyte, Inc. tweet media
English
0
0
0
62
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
Spatial Biology Services ➝ Spatial Biomarker Insights for Translational and Clinical Studies Analyze tissue biopsies with multiplexed biomarker panels at high throughput, unlocking valuable quantitative insights from large cohort studies. 💡 Learn more: rarecyte.com/partnerships/
RareCyte, Inc. tweet media
English
0
0
0
25
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
Upcoming webinar on easy strategies for reliable spatial biomarker results, presented by Simon Goldstein (@ljiresearch). Key topics: ✅ Validating antibody performance ✅ Designing and optimizing multiplex panels ✅ Sample preparation tips Register here: rarecyte.com/webinar-master…
RareCyte, Inc. tweet media
English
0
0
1
28
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
💡 #SpatialInsight: Hidradenitis suppurativa (HS) is a chronic, debilitating inflammatory skin disease. This @nyuniversity team examined the immune microenvironment within HS lesions. ➡️ Explore the interactive tissue atlas: #s=0#w=0#g=0#m=-1#a=-100_-100#v=0.5098_0.3769_0.4957#o=-100_-100_1_1#p=Q#r=100" target="_blank" rel="nofollow noopener">s3.us-east-1.amazonaws.com/www.cycif.org/… #Hidradenitis #Autoimmune
GIF
English
0
0
2
63
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
💥 18-plex imaging of breast duct harboring ductal carcinoma, acquired on the Orion spatial biology platform. 📸 This image, courtesy of Aditi Sanjay Khatpe, Stanford University, is featured in the RareCyte 2026 Calendar. View all calendar images: rarecyte.com/2026calendar/
RareCyte, Inc. tweet media
English
0
0
0
114
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
Hear how spatial proteomics could change clinical practice in the near future. Sandro Santagata @BrighamWomens is presenting at #SABCS25 on how multiplex protein analysis enables deeper, more efficient tumor profiling, going beyond single-marker IHC. ➡️ sabcs.org/events/transla…
RareCyte, Inc. tweet media
English
0
0
0
88
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
Heading to #SABCS25 next week? Don’t miss Karthik Giridhar's (@MayoClinic) poster on using CTC enumeration and ER/HER2 phenotyping to predict progression-free and overall survival in metastatic breast cancer. 🔬 Powered by the RareCyte CyteFinder Platform #AACR #BreastCancer
RareCyte, Inc. tweet media
English
0
0
0
76
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
RareCyte is honored to be this month's Life Science Washington Member Spotlight! Read the full spotlight ➡️ lifesciencewa.org/2025/11/13/mem… #LifeScienceWashington #SpatialBiology #LiquidBiopsy
Life Science WA@LifeScienceWA

Our next LSW Member Spotlight features @RareCyte! Their technologies are driving major advances in cancer research, immunotherapy development, and next-generation diagnostics by giving scientists insight into rare cells and complex tissue environments. lifesciencewa.org/2025/11/13/mem…

English
0
0
1
34
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
Labcluster Tour Paris is this week! Join our presentation on “Spatial Biology at Scale with Orion™ Technology” to discover the only multiplex immunofluorescence platform delivering 20 channels per round. Register for this free event ➡️ labcluster.com/LCTParis2025/e… #Labcluster
RareCyte, Inc. tweet media
English
0
0
0
30
RareCyte, Inc.
RareCyte, Inc.@RareCyte·
RareCyte is proud to sponsor AFC 2025 in Dijon, showcasing innovative platforms designed to complement and extend your cytometry research. 📍Stop by Booth #2 to learn about our spatial biology and liquid biopsy platforms. Event page: alphavisa.com/afc/2025/
RareCyte, Inc. tweet media
English
0
0
1
46